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The  abundance  of  supplemental 
material in The Journal of Experimental 
Medicine is growing. In the May 2011 
issue of JEM, all research papers have a 
supplement, with an average of 5.9 sup-
plementary items per paper. Only 3 yr 
ago (May 2008 issue), 16% of JEM papers 
had no supplementary items, and the 
overall average was 4.6 items per paper. 
3 yr before that (May 2005 issue), 57% 
of papers had no supplementary items, 
and  the  average  was  only  2.4  items   
per paper.
Why the increase in the prevalence 
of supplementary data? Reviewers fre-
quently  ask  for  it.  Editors  generally   
allow it. So authors are compelled to 
provide it, although some do so grudg-
ingly. Of course, authors are also refer-
ees.  Why  the  same  individual  would 
demand experiments as a referee that 
they might balk at as an author seems 
paradoxical.
What we can do to save authors 
and  referees  from  this  supplemental 
surplus is create a policy to address the 
problem. Effective immediately, sup-
plementary information in JEM Arti-
cles  and  Brief  Definitive  Reports 
(BDRs)  will  be  limited  to  essential 
supporting  information.  This  would 
include:  file  formats  not  currently 
amenable to inclusion in the primary 
paper (e.g., videos, large datasets, and 
genomic  data),  clinical  information   
(e.g., case reports and descriptions of 
patient populations), and complex de-
tailed methods required to reproduce 
data in the paper (e.g., chemistry re-
quired to synthesize and characterize 
compounds,  evidence  of  the  purity 
and  specificity  of  new  inhibitors  or   
antibodies,  or  flow  cytometry  gating 
strategies).
Our aim is to eliminate the use of 
the supplement as a “data dump.” For 
example,  additional  replicates  of  ex-
periments shown in the primary paper 
will no longer be included in the sup-
plement.  Data  documenting  that  a 
commercially available antibody does 
in fact deplete cells bearing its target, as 
shown by previous publications, will 
no  longer  be  in  the  supplement.  In 
some cases, especially with BDRs, the 
editors may decide that data unravel-
ing the mechanism underpinning a re-
ported phenomenon or phenotype are 
beyond the scope of the current man-
uscript. In these cases, authors will not 
be required to include data providing a 
preliminary “hint” at a mechanism in 
the supplement.
Although  we  encourage  authors 
to format new manuscripts in accor-
dance with this new policy, JEM will 
not  enforce  supplementary  informa-
tion limits at the time of submission. 
We  will,  however,  provide  detailed 
guidance  to  authors  of  manuscripts 
that  are  invited  back  after  external 
review.
Referees will be reminded of this 
new policy in the referee instructions 
letter  accompanying  each  manu-
script. However, we will inevitably 
encounter situations in which refer-
ees  request  substantial  amounts  of 
new experimental data. In these sce-
narios, the editors will provide au-
thors with explicit guidance. In some 
cases, we may feel that the requested 
data are beyond the scope of the cur-
rent manuscript. In others, the edi-
tors may agree that a large amount of 
new data would be needed to raise 
the conceptual scope and novelty of 
the  manuscript.  In  the  latter  situa-
tion, authors would need to refocus 
the paper rather than simply submit a 
revised paper that is twice its original 
size. In some cases, papers originally 
submitted as BDRs can be reformat-
ted as full Articles. However, we re-
alize  that  in  many  instances  the 
extent  of  required  refocusing  may 
ultimately result in the generation of 
a  manuscript  that  tells  a  distinctly 
different story from the original. We 
will emphasize this point in our com-
munication with authors.
The intention of the new policy is 
to curtail the escalating demand on the 
time and effort of authors, referees and 
editors, and to expedite the publication 
of  exciting  new  findings. As  with  all 
policy changes, we welcome your feed-
back and suggestions.
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Complaints about the overabundance of supplementary information in 
primary research articles have increased in decibel and frequency in the past 
several years and are now at cacophonous levels. Reviewers and editors 
warn that they do not have time to scrutinize it. Authors contend that the 
effort and money needed to produce it exceeds that reasonably spent on a 
single publication. How often readers actually look at supplemental infor-
mation is unclear, and most journal websites offer the supplement as an 
optional download.
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